Compare PAYS & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYS | SXTC |
|---|---|---|
| Founded | 2001 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 184.5M |
| IPO Year | 1998 | 2019 |
| Metric | PAYS | SXTC |
|---|---|---|
| Price | $5.41 | $1.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.06 | N/A |
| AVG Volume (30 Days) | ★ 329.3K | 210.7K |
| Earning Date | 11-12-2025 | 08-19-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $74,879,428.00 | $1,740,907.00 |
| Revenue This Year | $41.20 | N/A |
| Revenue Next Year | $20.62 | N/A |
| P/E Ratio | $41.87 | ★ N/A |
| Revenue Growth | ★ 32.61 | N/A |
| 52 Week Low | $1.80 | $0.95 |
| 52 Week High | $8.88 | $7.84 |
| Indicator | PAYS | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 53.08 | 57.87 |
| Support Level | $5.21 | $1.35 |
| Resistance Level | $5.60 | $1.78 |
| Average True Range (ATR) | 0.20 | 0.08 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 65.83 | 46.51 |
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.